EMP2 and non-small cell lung carcinoma: To examine the possible mechanisms by which EMP2 exerts cell growth inhibitory effects in NSCLC, Western blotting was carried out, showing that overexpression of EMP2 had different effects on alterations of pathways in H1299 and H2170 cells (Figure 5B).